Cardiac surgery in patients with liver cirrhosis – Uncalculatable risk or justified therapy? A retrospective survival-rate analysis of 47 patients within 8 years

Objectives: Patients with liver cirrhosis (LC) are considered as high risk population for cardiac surgery. Aim of this study was to review mortality and mid-term-outcome of patients with liver cirrhosis requiring coronary-artery-bypass grafting (CABG), valve-replacement or combined procedures. Methods: Between 7/97 and 12/06 47 patients (mean age 65.4±11.7 years) with liver cirrhosis were operated for CABG (21), AVR/MVR (14), CABG/VR (9) or aortic-dissection/tumor-exstirpation (3) (group I). 33 patients were classified as Child-Pugh (CP)-class A (subgroup A), 14 patients as CP-class B (subgroup B). Postoperative…